A randomized multicenter study of carboplatin-gemcitabine versus carboplatin-paclitaxel in elderly patients with non-small cell lung cancer with emphasis on geriatric assessment and quality of life: The NVALT-3 study.
Completed
- Conditions
- on Small Lungcancer (NSCLC) (NLD: Niet Kleincellig Longcarcinoom).
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 182
Inclusion Criteria
1. Histologically or cytologically confirmed inoperable (stage III) or disseminated (stage IV) non small cell lung cancer;
2. No previous chemo- and or radiotherapy;
Exclusion Criteria
1. Patients with a mixed form of NSCLC and SCLC;
2. Active uncontrolled infection;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare changes in quality of life between the two treatment groups from baseline as compared with quality of life at 18 weeks after start treatment.
- Secondary Outcome Measures
Name Time Method